Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...
The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks ...
The global market for barrett’s esophagus with dysplasia treatment is poised for significant growth, with a projected ...
Shares of Merck & Co. Inc. MRK inched 0.08% higher to $99.45 Tuesday, on what proved to be an all-around favorable trading ...
A Fremont pharmaceutical company received an investment of approximately $50 million in a private placement from Merck & Co.
A Fremont pharmaceutical company received an investment of approximately $50 million — about $3.56 per share — in a private ...
Treatment Market. According to a recent market analysis conducted by Future Market Insights, the global molluscum contagiosum ...
On Friday, Merck & Co Inc (MRK) stock saw a decline, ending the day at $98.05 which represents a decrease of $-1.47 or -1.48% from the prior close of $99.52. The stock opened at $98.83 and touched a ...
Merck, a leading global pharmaceutical company that produces a range of medicines, vaccines, and animal healthcare products, ...
Sanofi is handing SK bioscience 50 million euros ($52 million) as the longtime partners take their next-gen pneumococcal ...
About 87.5% of patients treated with the drug were alive after six years, compared to 83.2% who received a placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback